Concepedia

Matthew J. Bernett

MJ

Statistics

Publications

25

Citations

1.5K

H-Index

18

Active since

2001

Affiliations

Xencor (United States)(Current)

Florida State University

Amgen (United States)

Mayo Clinic

UNC Lineberger Comprehensive Cancer Center

Matthew J. Bernett is an author at Xencor (United States) specializing in medicine, immunology, and immunotherapy.

ORCID

Top concepts

Publications per year

2001–2023

25

Publications

25

Potent <i>In vitro</i> and <i>In vivo</i> Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia

Holly M. Horton, Matthew J. Bernett, Erik Pong et al. · Cancer Research · 2008 · 267 citations · Full text

Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals That a Trypsin-like Kallikrein Is Expressed in the Central Nervous System

Matthew J. Bernett, Sachiko I. Blaber, Isobel A. Scarisbrick et al. · Journal of Biological Chemistry · 2002 · 201 citations · Full text

Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release

Christina L. Zuch de Zafra, Flordeliza Fajardo, Wendy Zhong et al. · Clinical Cancer Research · 2019 · 123 citations

Targeting kallikrein 6‐proteolysis attenuates CNS inflammatory disease

Sachiko I. Blaber, Bogoljub Ćirić, Geroge P. Christophi et al. · The FASEB Journal · 2004 · 95 citations

, , +16

Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody

Seung Y. Chu, Holly M. Horton, Erik Pong et al. · Journal of Allergy and Clinical Immunology · 2012 · 92 citations

, , +12

Rows per page

1–5 of 25